Crossmark

Avelumab, una nueva inmunoterapia para pacientes con carcinoma de células de Merkel metastásico

Crossref DOI link: https://doi.org/10.1016/j.piel.2019.03.005

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Reguero del Cura, Leandra

Gómez Fernández, Cristina
License Information

Text and Data Mining valid from 2019-11-01
More Information

This article is maintained by: Elsevier

Article Title: Avelumab, una nueva inmunoterapia para pacientes con carcinoma de células de Merkel metastásico

Journal Title: Piel

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.piel.2019.03.005

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. All rights reserved.